|
Mechanism50S subunit inhibitors [+1] |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhaseWithdrawn |
First Approval Ctry. / Loc.United States |
First Approval Date29 Nov 1979 |
Complementary Intradialytic Nutritional Supplementation in Dialysis Patients
In this study, the investigators hypothesize that long-term administration of adequate intradialytic oral nutritional supplementation will increase visceral protein concentrations and somatic protein stores in malnourished chronic hemodialysis patients.
100 Clinical Results associated with Ross Laboratories S.E., Inc.
0 Patents (Medical) associated with Ross Laboratories S.E., Inc.
100 Deals associated with Ross Laboratories S.E., Inc.
100 Translational Medicine associated with Ross Laboratories S.E., Inc.